Safety, Tolerability and Pharmacokinetic Study of Multiple Rising Doses of TAK- 063 in Participants With Stable Schizophrenia and Healthy Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions

Schizophrenia

Interventions

DRUG

TAK-063

TAK-063 tablets

DRUG

TAK-063 Placebo

TAK-063 placebo-matching tablets

Trial Locations (1)

Glendale